Sun Pharmaceutical Industries Ltd (SUNPHARMA) - Financial and Strategic SWOT Analysis Review

Sun Pharmaceutical Industries Ltd (SUNPHARMA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the companys businesses and operations. The profile has been compiled to bring to you a clear and an unbiased view of the companys key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description A detailed description of the companys operations and business divisions.
- Corporate strategy Analysts summarization of the companys business strategy.
- SWOT Analysis A detailed analysis of the companys strengths, weakness, opportunities and threats.
- Company history Progression of key events associated with the company.
- Major products and services A list of major products, services and brands of the company.
- Key competitors A list of key competitors to the company.
- Key employees A list of the key executives of the company.
- Executive biographies A brief summary of the executives employment history.
- Key operational heads A list of personnel heading key departments/functions.
- Important locations and subsidiaries A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Sun Pharmaceutical Industries Ltd (Sun Pharma) is a specialty pharmaceutical company that offers a wide range of pharmaceutical formulations such as branded generics and generic pharmaceuticals. The companys portfolio includes products for the treatment of psychiatric, neurological, nephrological, gastroenterological, orthopedic and ophthalmologic diseases and disorders and heart diseases. The company carries out product development, process chemistry, and manufacture of complex active pharmaceutical ingredients (APIs), over-the-counter products and formulations. It offers drugs in various dosage forms such as tablets, capsules, injectables, inhalers, ointments, creams and liquids. The company has manufacturing facilities in North America, Latin America, EMEA and Asia Pacific. Sun Pharma is headquartered in Mumbai, Maharashtra, India.

Sun Pharmaceutical Industries Ltd Key Recent Developments

Jun 05,2020: Sun Pharma initiates Phase II clinical trial on AQCH, a phytopharmaceutical drug, as potential treatment for COVID-19 patients
May 27,2020: Sun Pharma reports Q4FY20 results
Mar 29,2020: Sun Pharmaceutical Industries: Update on Halol facility
Mar 27,2020: Sun Pharma commits donation of medicines and hand sanitizers to support Indias COVID-19 pandemic response
Dec 13,2019: Sun Pharmaceutical Industries: Update on US FDA Halol lnspection

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the companys business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The companys core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company




Section 1 - About the Company
Sun Pharmaceutical Industries Ltd - Key Facts
Sun Pharmaceutical Industries Ltd - Key Employees
Sun Pharmaceutical Industries Ltd - Key Employee Biographies
Sun Pharmaceutical Industries Ltd - Major Products and Services
Sun Pharmaceutical Industries Ltd - History
Sun Pharmaceutical Industries Ltd - Company Statement
Sun Pharmaceutical Industries Ltd - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Joint Venture
Section 2 Company Analysis
Company Overview
Sun Pharmaceutical Industries Ltd - Business Description
Business Segment: Bulk
Performance
Business Segment: Formulations
Overview
Performance
Business Segment: Others
Performance
Geographical Segment: Emerging markets
Performance
Geographical Segment: India
Performance
Geographical Segment: Rest of world
Performance
Geographical Segment: United States of America
Performance
R&D Overview
Sun Pharmaceutical Industries Ltd - Corporate Strategy
Sun Pharmaceutical Industries Ltd - SWOT Analysis
SWOT Analysis - Overview
Sun Pharmaceutical Industries Ltd - Strengths
Sun Pharmaceutical Industries Ltd - Weaknesses
Sun Pharmaceutical Industries Ltd - Opportunities
Sun Pharmaceutical Industries Ltd - Threats
Sun Pharmaceutical Industries Ltd - Key Competitors
Section 3 Company Financial Ratios
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts
Section 4 Companys Lifesciences Financial Deals and Alliances
Sun Pharmaceutical Industries Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Sun Pharmaceutical Industries Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2014 to YTD 2020
Sun Pharmaceutical Industries Ltd, Recent Deals Summary
Section 5 Companys Recent Developments
Jun 05, 2020: Sun Pharma initiates Phase II clinical trial on AQCH, a phytopharmaceutical drug, as potential treatment for COVID-19 patients
May 27, 2020: Sun Pharma reports Q4FY20 results
Mar 29, 2020: Sun Pharmaceutical Industries: Update on Halol facility
Mar 27, 2020: Sun Pharma commits donation of medicines and hand sanitizers to support Indias COVID-19 pandemic response
Dec 13, 2019: Sun Pharmaceutical Industries: Update on US FDA Halol lnspection
Dec 02, 2019: Ranbaxy Generic Drug Application Antitrust Litigation in US
Nov 07, 2019: Sun Pharma reports Q2FY20 results
Aug 13, 2019: Sun Pharma reports Q1FY20 results
Jun 28, 2019: Sun Pharma and CMS to commercialise CsA eye drops in China
Jun 21, 2019: Sun Pharmaceuticals update on US FDA Pre-Approval Inspection for Halol facility in Gujarat
Section 6 Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List Of Tables


Sun Pharmaceutical Industries Ltd, Key Facts
Sun Pharmaceutical Industries Ltd, Key Employees
Sun Pharmaceutical Industries Ltd, Key Employee Biographies
Sun Pharmaceutical Industries Ltd, Major Products and Services
Sun Pharmaceutical Industries Ltd, History
Sun Pharmaceutical Industries Ltd, Subsidiaries
Sun Pharmaceutical Industries Ltd, Joint Venture
Sun Pharmaceutical Industries Ltd, Key Competitors
Sun Pharmaceutical Industries Ltd, Ratios based on current share price
Sun Pharmaceutical Industries Ltd, Annual Ratios
Sun Pharmaceutical Industries Ltd, Annual Ratios (Cont...1)
Sun Pharmaceutical Industries Ltd, Annual Ratios (Cont...2)
Sun Pharmaceutical Industries Ltd, Interim Ratios
Sun Pharmaceutical Industries Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Sun Pharmaceutical Industries Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2014 to YTD 2020
Sun Pharmaceutical Industries Ltd, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List Of Figures


Sun Pharmaceutical Industries Ltd, Performance Chart (2016 - 2020)
Sun Pharmaceutical Industries Ltd, Ratio Charts
Sun Pharmaceutical Industries Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Sun Pharmaceutical Industries Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2014 to YTD 2020

SunVic Chemical Holdings Ltd (A7S) - Financial and Strategic SWOT Analysis Review

SunVic Chemical Holdings Ltd (A7S) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the companys businesses and operations. The profile has been compiled

USD 125 View Report

China Sunergy Co., Ltd. - Strategic SWOT Analysis Review

China Sunergy Co., Ltd. - Strategic SWOT Analysis Review provides a comprehensive insight into the companys history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis,

USD 125 View Report

Emzor Pharmaceutical Industries Ltd - Strategic SWOT Analysis Review

Emzor Pharmaceutical Industries Ltd - Strategic SWOT Analysis Review market research report available in single user pdf license with Aarkstore Enterprise at USD 125

USD 125 View Report

Teva Pharmaceutical Industries Ltd (TEVA) - Financial and Strategic SWOT Analysis Review

Teva Pharmaceutical Industries Ltd (TEVA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the companys businesses and operations. The profile has been compiled

USD 125 View Report

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available